CClinicalTrials.gg
CompletedNCT05712109FoVeAUpdated Mar 26, 2025

Changes in the Force-velocity Relationship of Knee Muscles After ACL Reconstruction

An observational study in Anterior Cruciate Ligament Injuries and Muscle Weakness, sponsored by University Hospital, Caen. Completed at 1 site in France. Open to participants aged 16 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-03-26.

Sponsored by University Hospital, Caen · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
103
Ages
16 Years to 55 Years
Sex
All
01

Study summary

Anterior cruciate ligament (ACL) tear is a frequent and devastating injury in sport, especially in pivoting-contact disciplines. In many cases, athletes will undergo an ACL reconstruction (ACL-R) for recovering knee stability, preventing further injuries and returning to sport (RTS). Among the criteria for RTS, knee muscle strength is the most used objective criteria and especially the symmetry of knee flexors and/or extensors between the operated and uninjured knee.

Isokinetic testing of knee muscle strength is considered as a reference for knee muscle testing during the follow up stages after ACL-R. This evaluation allows to measure the strength (torque) of knee flexors and extensors at several angular velocities. However, there is no relevant litterature about the force-velocity (Fo-v) relationship of knee flexors and extensors after ACL-R.

The present study aimed to evaluate and test the differences between the Fo-v relationship parameters between the operated and uninjured knees at 4 months and 8 months after ACL-R, using the 2-points method with isokinetic testing. Also, the investigators aimed to test the impact of the type of surgery (patellar tendon autograft vs. hamstring tendon autograft) on the Fo-v relationship after ACL-R

02

Conditions studied

  • Anterior Cruciate Ligament Injuries
  • Muscle Weakness
03

In context

Muscle Weakness

601 studies on the registry are indexed under Muscle Weakness; 99 are open to participants now.

This study's enrollment of 103 is close to the median of 98 across 144 observational studies indexed under Muscle Weakness.

Browse Muscle Weakness studies →

Lead sponsor

University Hospital, Caen is the lead sponsor of 505 studies on the registry; 80 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All sports patients included in the sport medicine follow-up protocole with isokinetic muscular assessment at 4 months and 8 months after ACL reconstruction surgery since January 2017

Inclusion criteria

  • Patients who have had an ACL reconstruction surgery (isolated or associated with other meniscal or ligamentary surgery)
  • Patient included in the sport medicine follow-up protocole with intermediate and final isokinetic muscular assessment at 4 months and8 months after surgery respectively
  • Patients who completed both tests at the 60°/s and 240°/s velocities

Exclusion criteria

Exclusion Criteria:

  • Patient who did not participate in all follow-up consultations and isokinetic muscular assessments
  • Cognitive or sensory impairment making it impossible to understand the information form
  • Neurological, traumatic or osteoarticular history responsible for muscle imbalance prior to surgery
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
103 participants (actual)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • ACL group

    The patients were referred to the sport medicine department for the post ACL-R follow-up including isokinetic knee muscle strength evaluations at 4 months and 8 months after the surgery

    Other: Follow-up after Anterior cruciate ligament reconstruction

Interventions

  • OtherFollow-up after Anterior cruciate ligament reconstruction

    The patients were referred to the sport medicine department for the post ACL-R follow-up including isokinetic knee muscle strength evaluations at 4 months and 8.months after the surgery

06

What researchers measure

Primary outcomes

  1. Change in strength

    Measurement of knee extensors and flexors peak strength (in newton.meter, Nm) on isokinetic dynamometer at two angular velocities of 60°/s and 240°/s respectively

    Time frame: Time Frame: ACL group: Two evaluations on both injured and healthy knees: (1) 4 months after surgery and (2) 8 months after surgery; Routine practice following guidelines

  2. Change in the force-velocity relationship

    Calculation of the corresponding slope and maximal force (Y-intercept) of the regression line of the force-velocity curve

    Time frame: Time Frame: ACL group: Two evaluations on both injured and healthy knees: (1) 4 months after surgery and (2) 8 months after surgery; Routine practice following guidelines

Secondary outcomes

  1. Individual characteristics

    Personal characteristics recorded in the medical report as age, gender, type of sport and sport level of practice and return to sport after the surgery

    Time frame: Time Frame: ACL group: Two evaluations on both injured and healthy knees: (1) 4 months after surgery and (2) 8 months after surgery; Routine practice following guidelines

  2. Injury characteristics

    Injury characteristics recorded in the medical report as the type of injury (ACL only, ACL and meniscus, ACL with other ligament injury, recurrent ACL injury) the time before surgery, the type of rehabilitation before and after surgery

    Time frame: Time Frame: ACL group: Two evaluations on both injured and healthy knees: (1) 4 months after surgery and (2) 8 months after surgery; Routine practice following guidelines

  3. Surgery characteristics

    Surgery characteristics recorded in the medical report as the type of surgery, the surgery duration and tourniquet time

    Time frame: Time Frame: ACL group: Two evaluations on both injured and healthy knees: (1) 4 months after surgery and (2) 8 months after surgery; Routine practice following guidelines

07

Study locations

1 site
  • CHU Caen Normandie
    Caen, 14000, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05712109
Lead sponsor
University Hospital, Caen
Responsible party
Sponsor
First posted
Feb 3, 2023
Start date
Jan 15, 2017
Primary completion
Jan 15, 2020
Completion
Feb 5, 2023
Last update
Mar 26, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion